Inhibitors of HCV replication
US7153848B2 · kind B2 · utility
62Cited by
0References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 14, 2005 |
| Grant date | Dec 26, 2006 |
| Priority date | — |
| Expiry date | Jul 14, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Indole compounds of Formula I are described. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV. Different forms and compositions comprising the compounds are also described as well as methods of preparing the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.